Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Eflornithine cream versus placebo for facial skin atrophy in women with facial hirsutism
2004-000726-78Phase 4Completed
- Sponsor
- Takeda
- Start
- Apr 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in hirsutism comparing Vaniqa cream with Placebo cream (2 arms). Primary endpoint: Change in treated facial skin thickness at week 24. Started Apr 2005; status: completed.
02
Drugs
eflornithine
03
Conditions
hirsutism
Beyond the preview
Go deeper on 2004-000726-78.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2004-000726-78.